ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in January 2025. Updated January 7, 2025.
A roundup of FDA’s actions in January 2025.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in January 2025. Updated January 7, 2025.
A roundup of FDA’s actions in January 2025.